Sort
48,018 grants matching “immunotherapy”
Core B: Computational
$413,235Alan S Perelson · Beth Israel Deaconess Medical Center · P01 · FY2019 · AI
Metabolic Control of Immune Suppression in Gliomas
$413,173Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2018 · NS
Metabolic Control of Immune Suppression in Gliomas
$413,173Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2019 · NS
Transplant EBV Disease: Pathogenesis and Immunotherapy
$413,164David T Rowe · University Of Pittsburgh At Pittsburgh · P50 · FY2007 · HL
Molecular Genetic Analysis of Mycobacterium tuberculosis
$413,135Albert Einstein Col Of Med Yeshiva Univ · R37 · FY2005 · AI
TECH Core
$413,131Kevin William Eliceiri · University Of Minnesota · U54 · FY2022 · CA
Radioimmunotherapy Combinations for B-cell Malignancy
$413,131Damian J. Green · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$413,121Vanderbilt University · U10 · FY2000 · CA
Reprogramming the Tumor Microenvironment in Ovarian Cancer
$413,104David D Schlaepfer · University Of California, San Diego · R01 · FY2021 · CA
CLINICAL IMAGING AND RADIATION DOSIMETRY
$413,077James R Bading · Beckman Research Institute/City Of Hope · P01 · FY2008 · CA
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy
$413,046Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2020 · CA
How IL-10R blockade can resolve persistent viral infections
$412,999Matthias G. Von Herrath · La Jolla Institute For Immunology · R01 · FY2010 · AI
Oncolytic Virus Therapeutic Responses Occur from Changes in the Glioblastoma Immune Microenvironment
$412,964E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2025 · NS
A Phase I Study of Lentivirus Safety During T-Cell Immu
$412,957City Of Hope/Beckman Research Institute · P01 · FY2005 · AI
Biostatistics Facility
$412,921Daniel P. Normolle · University Of Pittsburgh At Pittsburgh · P30 · FY2020 · CA
Project 2: Spatial Architecture of Tumor-Mediated Immunosuppression
$412,868Garry P Nolan · Stanford University · U54 · FY2018 · CA
Allergen T cell epitopes and phenotypes during peanut immunotherapy
$412,840Erik Wambre · Benaroya Research Inst At Virginia Mason · U19 · FY2018 · AI
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure
$412,810Mark W Jackson · Case Western Reserve University · R01 · FY2025 · CA
Unbiased electrothermal flow-enhanced identification of antigen-specific T cells in lung cancer
$412,768Alexandre Reuben · University Of Tx Md Anderson Can Ctr · R21 · FY2023 · CA
Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy
$412,739Simon Eschweiler · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Elucidating the Roles of RNA m6A readers Y1 and Y2 in radiation-induced immunity and immunotherapy
$412,712Ralph R Weichselbaum · University Of Chicago · R01 · FY2021 · CA
Oncolytic virus therapeutic responses occur from changes in the glioblastoma immune microenvironment
$412,687E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2021 · NS
Oncolytic virus therapeutic responses occur from changes in the glioblastoma immune microenvironment
$412,687E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2023 · NS
Oncolytic virus therapeutic responses occur from changes in the glioblastoma immune microenvironment
$412,687E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2022 · NS
Functional interplay between Hippo and estrogen receptor ESR1
$412,680Jing Yang · University Of California, San Diego · R01 · FY2024 · CA